Large study shows that abacavir doesn't increase short or long-term risk of heart attack
More than twice the risk of failure for patients starting on abacavir with low CD4s or high viral loads, compared with tenofovir
Treatment breaks lead to fibrosis in HIV/HCV-co-infected patients
HIV drug prescribing in London to change from this month
